NasdaqGS - Delayed Quote USD
Nkarta, Inc. (NKTX)
1.7400
+0.0200
+(1.16%)
At close: May 16 at 4:00:00 PM EDT
1.7199
-0.02
(-1.16%)
After hours: May 16 at 4:31:45 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.35 | -0.35 | -1.48 | -1.29 |
| Low Estimate | -0.5 | -0.51 | -1.95 | -1.43 |
| High Estimate | -0.25 | -0.26 | -1.21 | -1.15 |
| Year Ago EPS | -0.34 | -0.39 | -1.6 | -1.48 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | 1.5M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 9M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.51 | -0.36 | -0.4 | -0.45 |
| EPS Actual | -0.34 | -0.39 | -0.35 | -0.43 |
| Difference | 0.18 | -0.03 | 0.05 | 0.02 |
| Surprise % | 33.98% | -9.09% | 12.50% | 4.44% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.35 | -0.35 | -1.48 | -1.29 |
| 7 Days Ago | -0.37 | -0.33 | -1.45 | -1.3 |
| 30 Days Ago | -0.37 | -0.33 | -1.45 | -1.3 |
| 60 Days Ago | -0.43 | -0.44 | -1.85 | -2.37 |
| 90 Days Ago | -0.43 | -0.44 | -1.85 | -2.37 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 3 | 2 |
| Up Last 30 Days | 1 | 2 | 3 | 2 |
| Down Last 7 Days | 2 | 1 | 1 | -- |
| Down Last 30 Days | 2 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NKTX | -2.94% | 10.26% | 7.29% | 13.03% |
| S&P 500 | 13.21% | 2.76% | 7.83% | 13.78% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 5/15/2025 |
| Downgrade | William Blair: Outperform to Market Perform | 5/15/2025 |
| Reiterates | Needham: Buy to Buy | 4/9/2025 |
| Maintains | Stifel: Buy to Buy | 3/27/2025 |
| Reiterates | Needham: Buy to Buy | 3/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/27/2025 |
Related Tickers
IPSC Century Therapeutics, Inc.
0.5600
+8.23%
HLVX HilleVax, Inc.
1.9700
+0.51%
IKNA Ikena Oncology, Inc.
1.1100
+0.91%
RPTX Repare Therapeutics Inc.
1.3400
+0.75%
CRGX CARGO Therapeutics, Inc.
4.1200
+3.26%
FATE Fate Therapeutics, Inc.
1.0700
+5.94%
KZR Kezar Life Sciences, Inc.
4.0700
+0.25%
OKUR OnKure Therapeutics, Inc.
2.0000
-2.91%
PMVP PMV Pharmaceuticals, Inc.
0.8659
+3.32%
ITOS iTeos Therapeutics, Inc.
7.81
-2.01%